Announcement on 2024 Annual Profit Distribution Scheme
Filed with SSE · · 4 pages · Chinese
Changchun BCHT Biotechnology Co. on 6ix
Earlier from Changchun BCHT Biotechnology
- Announcement on Convening Performance Briefing for 2024 and Q1 2025
- Announcement on Resolution of the 1st Extraordinary General Meeting in 2025
- Notice on Convening the 1st Extraordinary General Meeting in 2025
- Announcement on Preliminary Earnings Estimate for 2024
- Announcement on Resignation of Director and Senior Management Member
Later from Changchun BCHT Biotechnology
- Announcement on Resolution of the 2024 Annual General Meeting
- Announcement on Attending 2025 Online Collective Reception Day for Investors of Listed Companies in Jilin Jurisdiction
- Announcement on Voluntary Disclosure of Approval for Clinical Trial Application of Recombinant Zoster Vaccine (CHO Cell)
- Announcement on Implementation of Dividend Distribution for 2024
- Announcement on Voluntary Disclosure of Obtaining Approval of Clinical Trial for Split-Virion Influenza Vaccine (BK-01 Adjuvant)
Follow Changchun BCHT Biotechnology into a list and get an email when it puts out news.
Follow Changchun BCHT Biotechnology